Medtronic has reported revenue gains across several of its medical device franchises, leading the company to ... aortic valve ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...

The American Heart Association held its annual Scientific Sessions Nov. 16-18 in Chicago, where healthcare organizations and industry leaders presented the latest research on cardiovascular health.